CHARLOTTESVILLE, Va.,
March 28, 2024 /PRNewswire/ --
RIVANNA®, a developer of imaging-based medical
solutions, names Craig Loomis as
senior director of product management. With over 25 years of
extensive experience in global product development and
commercialization within the healthcare sector, Mr. Loomis will
play a vital role in advancing RIVANNA's new product
commercialization strategies.
Before joining RIVANNA, Mr. Loomis held progressively
responsible roles at GE Healthcare in product development across
CT, MR, X-ray, ECG (diagnostic cardiology) and point-of-care
ultrasound. Notably, he spearheaded the introduction of the
market-leading Venue product family. His contributions include
holding several patents, successfully developing, or launching over
30 products throughout his career and managing portfolios exceeding
$200 million.
"I'm thrilled to join at this crucial state of product
commercialization," said Loomis. "With numerous products in
development, RIVANNA is poised to impact healthcare significantly.
I'm eager to leverage my experience to help RIVANNA bring these
innovations to market and improve patient outcomes worldwide."
RIVANNA has groundbreaking products under development, including
a rapid, radiation-free fracture detection system developed in
partnership with the Biomedical Advanced Research and Development
Authority, part of the Administration for Strategic Preparedness
and Response within the U.S. Department of Health and Human
Services, and an AI-enabled 3D image-guided system designed to
overcome barriers to real-time neuraxial needle guidance through a
unique hands-free and split array imaging technology.
"Craig's proven track record in driving revenue growth,
launching innovative products and cultivating customer
relationships will be pivotal in driving the successful adoption of
Accuro 3S within the acute pain neuraxial market and its adjacent
indications, which collectively represent a total addressable
market exceeding $1
billion," comments Will
Mauldin, PhD, RIVANNA co-founder and CEO.
Craig holds a Master of Business Administration from the
University of Chicago Booth School of
Business and bachelor's and master's degrees in computer
engineering from the Rochester Institute of
Technology.
The Accuro XV project is funded in whole or in part with funds
from the U.S. Department of Health and Human Services,
Administration for Strategic Preparedness and Response, Biomedical
Advanced Research and Development Authority, under contract
75A50121C00035.
ABOUT RIVANNA
RIVANNA® is a
commercial-stage medical device innovator and manufacturer in
Charlottesville, Va. RIVANNA's
mission is to develop and commercialize world-first imaging-based
medical technologies that elevate global standards of care.
RIVANNA's technology platform combines the benefits of ultrasound
with the bone imaging capabilities of x-ray to fill unmet clinical
needs. BoneVision™ and BoneEnhance® optimize
ultrasound image acquisition and visualization to provide
radiation-free alternatives to x-ray-based imaging. When paired
with SpineNav3D™ AI-enabled image recognition, the
platform provides comprehensive clinician assistance that improves
decision-making, clinician workflows, health outcomes, and patient
satisfaction. The company operates an FDA-registered and ISO
13485:2016 certified manufacturing facility where it produces the
Accuro® product line and related medical equipment and
components. For more information, visit rivannamedical.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rivanna-appoints-craig-loomis-as-senior-director-of-product-management-302103527.html
SOURCE Rivanna Medical